Clinical Trials Browser

Phase 1/2 × OTHER × Denosumab × Clear all

NCT06374459 2026-02-09

Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis

Phase 1/2 Recruiting

Breast Neoplasms

NCT03161756 2022-04-07

CHARLI

Phase 1/2 Unknown

Melanoma

NCT03415477 2018-01-30

Deno-ABC

Phase 1/2 Completed

Fractures, Spontaneous, Neoplasms, Recurrence, Bone Cysts, Aneurysmal